Ryszard Kole
Plus aucun poste en cours
Historique de carrière de Ryszard Kole
Anciens postes connus de Ryszard Kole
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Directeur Technique/Scientifique/R&D | 01/01/2001 | - |
President | 01/01/2001 | - | |
The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 10/04/2008 | - |
Formation de Ryszard Kole
Polish Academy of Sciences | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Pologne | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
- Bourse
- Insiders
- Ryszard Kole
- Expérience